ADGM$0.0862-0.92%
Adagio Medical Holdings, Inc.
Sector: Surgical & Medical Instruments & ApparatusIndustry: Medical - DevicesCountry: USExchange: Nasdaq
Mkt Cap:$2.37M
Float & O/S:
Inst Own:
DilutionScan read 37 of Adagio Medical Holdings, Inc.'s SEC filings and found 6 warrant series, 1 convertible, 1 shelf registration, 2 S-1 registrations and 1 completed offering on file for ADGM. The latest dilution event on file is a conversion repricing on Sep 23, 2026. Analysis updated Oct 31, 2026.
Signal8 Summary
ADGM
Cash-strapped micro-cap facing delisting
Snapshot
Adagio Medical is a pre-revenue medical device company developing heart-ablation catheters, with FY 2025 revenue effectively at zero and a net loss of $25.1M.
What's Happening Right Now
- : Q2 2026 net loss was $6.7M with no revenue due to a pause in European sales, and cash fell from $17.1M to $7.7M, tightening the company's financial runway.
- : Adagio treated its first patient with a next-generation faster ablation catheter under FDA expanded access and got approval to expand its ongoing heart-rhythm trial to test it.
- : At its June 16, 2026 annual meeting, shareholders elected two directors and ratified the company's accounting firm for fiscal 2026.
- : Nasdaq warned Adagio that its stock has traded below the $1.00 minimum price for 30 days straight, starting a 180-day clock to fix it or risk delisting.
